MIRA Pharmaceuticals, Inc. Amortization of Debt Issuance Costs
MIRA Pharmaceuticals, Inc. (MIRA) reported Amortization of Debt Issuance Costs of $732.29 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-11-12
- MIRA Pharmaceuticals, Inc. amortization of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- MIRA Pharmaceuticals, Inc. amortization of debt issuance costs for the quarter ending 2023-09-30 was $439.38K.
- MIRA Pharmaceuticals, Inc. amortization of debt issuance costs for fiscal 2023 was $732.29K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $439.38K derived: sum of 2 quarters · filed 2024-11-12 | $732.29K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $439.38K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-12 | $732.29K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $292.92K 10-Q/A · filed 2024-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |